Plain-English translation of NCT05046080 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at M.D. Anderson Cancer Center are studying a rare type of cervical cancer called clear cell carcinoma. This study looks at patient medical records and archived tumor tissue samples to learn more about how this cancer develops and behaves at the cellular and genetic level.
Clear cell carcinoma of the cervix is very uncommon, so doctors don't have as much information about it as they do for more common cervical cancers. By studying existing patient cases and their tissue samples, researchers hope to better understand this cancer type and eventually improve how it is diagnosed and treated.
You likely qualify if…
You likely don't qualify if…
Participation is simple and non-invasive. Researchers will review your existing medical records and examine tissue samples that were already collected during your cancer care. You will not need to visit the hospital for new tests or procedures—the study uses information and samples already in your medical file.
AI-generated summary from trial data · Aug 16, 2026 · Not medical advice
United States
Sponsor
M.D. Anderson Cancer Center
Enrollment target
~70 participants
Started
August 2021
Primary completion
September 2026
Sex
Female only
Last updated on clinicaltrials.gov in August 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.